International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma.
Tine Gadegaard HindsøBita EsmaeliFrederik HolmLauge Hjorth MikkelsenPeter Kristian RasmussenSarah E CouplandPaul T FingerGerardo F GraueHans E GrossniklausSantosh G HonavarJwu Jin KhongPenelope A McKelvieKaustubh MulayLene Dissing SjöGeeta K VemugantiBradley A ThuroSteffen HeegaardPublished in: The British journal of ophthalmology (2019)
EMZL is a slow-growing tumour with an excellent long-term survival. Low-dose EBRT as monotherapy should be considered in localised OA-EMZL. Rituximab-based chemotherapy should be chosen in those patients with disseminated disease.